483
MassBiologicsMassBiologics – FDA 483, Sep 1, 2022
Record Details
An FDA inspection of MassBiologics in Boston, MA, a vaccine manufacturer, revealed significant deficiencies across three observations. These issues include inadequate aseptic filling procedures, disorganized and potentially compromised storage of in-process and finished product samples, and a general lack of cleanliness and sanitation in manufacturing and storage facilities. The findings indicate a need for improved contamination control and adherence to good manufacturing practices.
View Company Profile
ID · 7697ffb3-e3e5-4b7c-b35f-71dbfed07048
Other documents for MassBiologics
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.